CD19/CD20 dual-targeted chimeric antigen receptor-engineered natural killer cells exhibit improved cytotoxicity against acute lymphoblastic leukemia

被引：0
作者：
Na Yang
Caili Zhang
Yingchun Zhang
Yuting Fan
Jing Zhang
Xiaojin Lin
Ting Guo
Yangzuo Gu
Jieheng Wu
Jianmei Gao
Xing Zhao
Zhixu He
机构：
[1] Guizhou Medical University (GMU),Tissue Engineering and Stem Cell Experiment Center
[2] Guizhou Medical University,Department of Immunology, College of Basic Medical Sciences
[3] Guizhou Medical University,Department of Biology, School of Basic Medical Sciences
[4] the Affiliated Hospital of Guizhou Medical University,Department of Gynecology
[5] Sichuan University,State Key Laboratory of Biotherapy and Cancer Center
[6] Zunyi Medical University,School of Pharmacy
[7] Chinese Academy of Medical Sciences),Key Laboratory of Adult Stem Cell Translational Research
[8] the Affiliated Hospital of Zunyi Medical University,Department of Pediatrics
来源：
Journal of Translational Medicine | / 22卷
关键词：
Chimeric antigen receptor; Natural killer cells; Dual targets; mRNA; Acute lymphoblastic leukemia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 45 条
  • [1] CD19/CD20 dual-targeted chimeric antigen receptor-engineered natural killer cells exhibit improved cytotoxicity against acute lymphoblastic leukemia
    Yang, Na
    Zhang, Caili
    Zhang, Yingchun
    Fan, Yuting
    Zhang, Jing
    Lin, Xiaojin
    Guo, Ting
    Gu, Yangzuo
    Wu, Jieheng
    Gao, Jianmei
    Zhao, Xing
    He, Zhixu
    JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
  • [2] High Cytotoxic Efficiency of Lentivirally and Alpharetrovirally Engineered CD19-Specific Chimeric Antigen Receptor Natural Killer Cells Against Acute Lymphoblastic Leukemia
    Mueller, Stephan
    Bexte, Tobias
    Gebel, Veronika
    Kalensee, Franziska
    Stolzenberg, Eva
    Hartmann, Jessica
    Koehl, Ulrike
    Schambach, Axel
    Wels, Winfried S.
    Modlich, Ute
    Ullrich, Evelyn
    FRONTIERS IN IMMUNOLOGY, 2020, 10
  • [3] Targeting CD5 chimeric antigen receptor-engineered natural killer cells against T-cell malignancies
    Zu, Yingling
    Ren, Quan
    Zhang, Jishuai
    Su, Hongchang
    Lu, Qiumei
    Song, Yongping
    Zhou, Jian
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2024, 13 (01)
  • [4] Novel chimeric antigen receptor targets and constructs for acute lymphoblastic leukemia: Moving beyond CD19
    Acharya, Luna
    Garg, Alpana
    Rai, Manoj
    Kshetri, Rupesh
    Grewal, Udhayvir S.
    Dhakal, Prajwal
    JOURNAL OF INVESTIGATIVE MEDICINE, 2024, 72 (01) : 32 - 46
  • [5] Efficacy and safety of CD19 CAR T constructed with a new anti-CD19 chimeric antigen receptor in relapsed or refractory acute lymphoblastic leukemia
    Gu, Runxia
    Liu, Fang
    Zou, Dehui
    Xu, Yingxi
    Lu, Yang
    Liu, Bingcheng
    Liu, Wei
    Chen, Xiaojuan
    Liu, Kaiqi
    Guo, Ye
    Gong, Xiaoyuan
    Lv, Rui
    Chen, Xia
    Zhou, Chunlin
    Zhong, Mengjun
    Wang, Huijun
    Wei, Hui
    Mi, Yingchang
    Qiu, Lugui
    Lv, Lulu
    Wang, Min
    Wang, Ying
    Zhu, Xiaofan
    Wang, Jianxiang
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
  • [6] Point of care CD19 chimeric antigen receptor (CAR) T-cells for relapsed/ refractory acute myeloid leukemia (AML) with aberrant CD19 antigen expression
    Danylesko, Ivetta
    Shem-Tov, Noga
    Yerushalmi, Ronit
    Jacoby, Elad
    Toren, Amos
    Shouval, Roni
    Itzhaki, Orit
    Avigdor, Abraham
    Shimoni, Avichai
    Nagler, Arnon
    CURRENT RESEARCH IN TRANSLATIONAL MEDICINE, 2024, 72 (04)
  • [7] Efficacy and safety of CD19 CAR T constructed with a new anti-CD19 chimeric antigen receptor in relapsed or refractory acute lymphoblastic leukemia
    Runxia Gu
    Fang Liu
    Dehui Zou
    Yingxi Xu
    Yang Lu
    Bingcheng Liu
    Wei Liu
    Xiaojuan Chen
    Kaiqi Liu
    Ye Guo
    Xiaoyuan Gong
    Rui Lv
    Xia Chen
    Chunlin Zhou
    Mengjun Zhong
    Huijun Wang
    Hui Wei
    Yingchang Mi
    Lugui Qiu
    Lulu Lv
    Min Wang
    Ying Wang
    Xiaofan Zhu
    Jianxiang Wang
    Journal of Hematology & Oncology, 13
  • [8] Treatment with anti CD19 chimeric antigen receptor T cells after antibody-based immunotherapy in adults with acute lymphoblastic leukemia
    Danylesko, Ivetta
    Chowers, Guy
    Shouval, Roni
    Besser, Michal J.
    Jacoby, Elad
    Shimoni, Avichai
    Nagler, Arnon
    Avigdor, Abraham
    CURRENT RESEARCH IN TRANSLATIONAL MEDICINE, 2020, 68 (01) : 17 - 22
  • [9] How to train your T cell: genetically engineered chimeric antigen receptor T cells versus bispecific T-cell engagers to target CD19 in B acute lymphoblastic leukemia
    Ruella, Marco
    Gill, Saar
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2015, 15 (06) : 761 - 766
  • [10] Dual targeting of glioblastoma with chimeric antigen receptor-engineered natural killer cells overcomes heterogeneity of target antigen expression and enhances antitumor activity and survival
    Genssler, Sabrina
    Burger, Michael C.
    Zhang, Congcong
    Oelsner, Sarah
    Mildenberger, Iris
    Wagner, Marlies
    Steinbach, Joachim P.
    Wels, Winfried S.
    ONCOIMMUNOLOGY, 2016, 5 (04):
12345